Allogene Therapeutics competitorsClear all
Allogene Therapeutics's top competitors include Novartis, Amgen, Bellicum Pharmaceuticals, Gilead Sciences, Cellectis and Legend Biotech.
 Allogene Therapeutics Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T therapies for cancer. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. |  Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. |  Cellectis Cellectis is a biopharmaceutical company focused on developing develop a new generation of cancer immunotherapies based on engineered allogeneic T-cells. |  Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
| |
Founding Date | Founding Date 2018 | Founding Date 1996 | Founding Date 1980 | Founding Date 2004 | Founding Date 1987 | Founding Date 1999 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations South San Francisco, US HQ | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Machelen, BE Santo Amaro, BR see more | Locations Houston, US HQ Houston, US Houston, US South San Francisco, US | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Paris, FR HQ Lyon, FR New York, US Raleigh, US | Locations Piscataway, US HQ Nanjing, CN Nanjing Shi, CN Dublin, IE Franklin Township, US Franklin Township, US | |
Employees | Employees 2058% increase | Employees 110,0004% increase | Employees 24,200 | Employees 10738% decrease | Employees 14,4006% increase | Employees 272 | Employees 650 |
Valuation ($) | Valuation ($) 1 b | Valuation ($) N/A | Valuation ($) 137.9 b | Valuation ($) 13.3 m | Valuation ($) 78.1 b | Valuation ($) 140.8 m | Valuation ($) 5.4 b |
Twitter followers | Twitter followers 2 k | Twitter followers 299.8 k | Twitter followers 105.3 k | Twitter followers 580 | Twitter followers 70.7 k | Twitter followers 4.5 k | Twitter followers 617 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 16 | Number of tweets (last 30 days) 32 | Number of tweets (last 30 days) 136 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 26 | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) 6 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 6.5 | Average likes per tweet (last 30 days) 10.8 | Average likes per tweet (last 30 days) 5.9 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 155.8 | Average likes per tweet (last 30 days) 3.1 | Average likes per tweet (last 30 days) 2 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 37.5% | Percentage of tweets with engagement (last 30 days) 95.59% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 703432 | Alexa Website Rank 102511 | Alexa Website Rank 181163 | Alexa Website Rank 211878 | Alexa Website Rank 128868 | Alexa Website Rank 324396 | Alexa Website Rank 393967 |
Employee Rating | Employee Rating 4.4 | Employee Rating N/A | Employee Rating N/A | Employee Rating 2.7 | Employee Rating 3.8 | Employee Rating 2.9 | Employee Rating 3.5 |
Financial | |||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $52.9b (FY, 2021) | Revenue (est.) $26b (FY, 2021) | Revenue (est.) $500k (FY, 2020) | Revenue (est.) $27.3b (FY, 2021) | Revenue (est.) $73.9m (FY, 2020) | Revenue (est.) $75.7m (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods ($9.7b) (FY, 2021) | Cost of goods $6.5b (FY, 2021) | Cost of goods N/A | Cost of goods $6.6b (FY, 2021) | Cost of goods ($39.7m) (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $45.1b (FY, 2021) | Gross profit $19.5b (FY, 2021) | Gross profit N/A | Gross profit $20.7b (FY, 2021) | Gross profit $42.7m (FY, 2020) | Gross profit N/A |
Net income | Net income ($250.2m) (FY, 2020) | Net income $24b (FY, 2021) | Net income $5.9b (FY, 2021) | Net income ($7.7m) (FY, 2020) | Net income $6.2b (FY, 2021) | Net income ($97.5m) (FY, 2020) | Net income ($303.5m) (FY, 2020) |
Operating ⚠ | |||||||
Countries | Countries N/A | Countries N/A | Countries 100 (FY, 2020) | Countries N/A | Countries 35 (FY, 2020) | Countries N/A | Countries N/A |
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) 31 (FY, 2020) | Patents (US) N/A | Patents (US) 650 (Dec, 2020) | Patents (US) N/A | Patents (US) N/A |
Phase I Trials Products | Phase I Trials Products 4 (FY, 2019) | Phase I Trials Products N/A | Phase I Trials Products 20 (FY, 2020) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 54 (FY, 2021) | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products N/A | Phase III Trials Products 8 (FY, 2020) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 27 (FY, 2021) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 3 (FY, 2020) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A |
Funding | |||||||
Total funding raised | Total funding raised $ 532m | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.2m | Total funding raised $ 150.5m |
For sources of this data, please see the company profile
View company profiles
Novartis
HQ
Basel, CH
Employees
110,000↑ 4% increase
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyAmgen
HQ
Thousand Oaks, US
Employees
24,200
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
View companyBellicum Pharmaceuticals
HQ
Houston, US
Employees
107↓ 38% decrease
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
View companyGilead Sciences
HQ
Foster City, US
Employees
14,400↑ 6% increase
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View company